PYC Therapeutics Ltd (PYC) — Capital Reinvestment Ratio

Latest as of June 2017: 0.00x

PYC Therapeutics Ltd (PYC) has a Capital Reinvestment Ratio of 0.00x as of June 2017, meaning it reinvests 0% of its operating cash flow (AU$1.73 Million) in capital expenditures (AU$608.00). See PYC equity financing ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x
Capex / Operating Cash Flow

Operating Cash Flow

AU$1.73 Million
AUD

Capital Expenditures

AU$608.00
AUD

Data as of

Jun 2017
Most recent filing

PYC Therapeutics Ltd Capital Reinvestment Ratio (2004–2004)

This chart tracks PYC Therapeutics Ltd's Capital Reinvestment Ratio across 1 annual periods. Check PYC Therapeutics Ltd (PYC) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for PYC Therapeutics Ltd (2004–2004)

Year-by-year Capital Reinvestment Ratio for PYC Therapeutics Ltd from 2004 to 2004. For live market cap and broader valuation context, see PYC Therapeutics Ltd (PYC) total market value.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2004 0.11x AU$28.00K AU$3.00K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow